key: cord-032244-s7t5u9lf authors: Valente, Serafina; Colivicchi, Furio; Caldarola, Pasquale; Murrone, Adriano; Di Lenarda, Andrea; Roncon, Loris; Amodeo, Enzo; Aspromonte, Nadia; Cipriani, Manlio Gianni; Domenicucci, Stefano; Francese, Giuseppina Maura; Imazio, Massimo; Scotto di Uccio, Fortunato; Urbinati, Stefano; Gulizia, Michele Massimo; Gabrielli, Domenico title: ANMCO POSITION PAPER: Considerations on in-hospital cardiological consultations and cardiology outpatient clinics during the COVID-19 pandemic date: 2020-08-27 journal: Eur Heart J Suppl DOI: 10.1093/eurheartj/suaa112 sha: doc_id: 32244 cord_uid: s7t5u9lf Infections by SARS CoV2 - COVID-19 have become in a short time a worldwide health emergency. Due to cardiovascular implications of COVID-19 and to very frequent previous cardiovascular disorders of COVID-19 patients, it is presently crucial that Cardiologists are fully aware of COVID-19 related epidemiological, pathophysiological and therapeutic problems, in order to manage at best the present emergency by appropriate protocols developed on the basis of the competences acquired and shared on the field. The aim of this document is to propose algorithms for the management of cardiovascular diseases during COVID-19 emergency with the objective of providing patients with optimal care, minimizing contagion risk and appropriately managing personal protective equipment. Over a short period of time, COVID-19 infection has become a worldwide problem and a health emergency. 1 Today it is crucial that cardiologists know this disease in its epidemiology, pathophysiological, and therapeutic aspects, in order to better manage the ongoing emergency through protocols proposed on the basis of shared experiences. The reasons underlying the importance of COVID-19 infection for cardiologists are as follows: • It is a pandemic that affects everyone, especially cardiovascular patients, as shown by Chinese cases 2-6 ; • COVID-19 patients may have cardiovascular complications, although they are not so frequent 7, 8 ; • Cardiovascular disease continues to be prevalent in the general population and patients with acute coronary syndrome may at the same time be positive for COVID-19. 9, 10 The objective of this document is to propose management algorithms for cardiovascular disease during the COVID-19 emergency, in order to optimize cardiological assistance for the benefit of patients by minimizing the possibility of contagion, safeguarding healthcare personnel, and rationalizing the use of personal protective equipment (PPE). 11, 12 All patients who come for cardiological evaluation must be screened for COVID-19 infection and should result negative on the diagnostic test (unless it is an emergency). In many regions (see also Ministry of Health Circular prot. 7422-16/03/2020) only outpatient activities with U and B priorities were maintained (moreover, in many hospitals access is restricted to only type U priorities due to regulations). Obviously, all activities possible through telephone consultation or better by telemedicine must be promoted. • Clinical staff should contact patients scheduled for appointments the day before to confirm appointments and give precise instructions on how to carry them out and to propose a COVID-19 screening. • Every effort should be made to minimize the number of patients present at the same time by distancing appointments and providing large waiting rooms with adequate social distance (see also National Institute of Health (NIH) and regional indications). • During the appointment or the diagnostic test, it is important to minimize the exposure of healthcare personnel and always provide a surgical mask for the patient to wear. • Try to avoid redundancy of medical exams and diagnostic tests. • Try to facilitate access for priority U patients at local level outpatient treatment centres to reduce the burden on hospitals. Urgent evaluation is needed (referring to priorities U or B) in the case of patients with (also referring to regional RAO): De novo presentation of: • chest pain or equivalent with high a priori risk of coronary heart disease; • dyspnoea or equivalent with suspected heart failure (warning-dyspnoea is also a COVID-19 symptom, so it is necessary to ask the patient before access to clinic); • palpitations with syncope and/or signs of poor haemodynamic tolerance; and • syncope of suspected cardiac origin. Exacerbation or refractoriness of: • angina pectoris • heart failure • arrhythmia In the case of a suspected COVID-19 patient, it is always necessary to try to postpone the medical exam or the appointment (if a cardiac patient cannot wait, refer them to the emergency room which has appropriate access points and safety procedures in place) or manage with the available PPE according to the risk of contagion following specific safety procedures, remembering to disinfect spaces and equipment after the exam/appointment according to local protocols. [13] [14] [15] and drugs that prolong the QTc interval. An ECG and dosage of N-terminal fragment of the propeptide of brain natriuretic, along with telematic consultations on specific pharmacological therapy are necessary for patients hospitalized for COVID-19 with known heart disease and heart failure already undergoing pharmacological treatment. Telematic cardiology consultations and troponin I and N-terminal pro-B-type natriuretic peptide dosages are necessary in cases of patients with COVID-19 and symptoms of high-risk non-ST-segment elevation myocardial infarction. If the cardiologist, in the presence of a favourable risk/benefit ratio, considers it useful to perform an echocardiogram, the operator must be protected with total protection PPE and FFP3 masks (maximum protection). Please refer to specific Acute Heart Failure (AHF) protocols. If the critical care physician and cardiologist are in agreement and in presence of a favourable risk/benefit ratio, an echocardiogram may be administered to rule out severe myocardial damage. The operator must be protected with total protection PPE and FFP3 masks (maximum protection). Keep in mind the frequent increase in troponin in COVID-19 patients, expression of non-ischaemic acute myocardial injury. Arrhythmias are relatively frequent in COVID-19 patients. The cardiac evaluation may be performed telematically, S. Valente et al. after possible telephone contact with the referring doctor, for therapeutic advice. Please refer to specific arrhythmology protocols. Before carrying out cardiology consultations in the emergency room or in other wards, it is necessary to perform a quick telephone interview about the presence of flu and/ or respiratory symptoms in the patient. In the case of suspected symptomatology and if it is not possible to wait for the swab results, the patient must be considered positive for COVID-19 and maximum protection measures must be taken. In all other cases, it is necessary to make consultations with disposable gowns and surgical masks, making sure that the patient always wears a surgical mask. In COVID-19 patients, only cardiology consultations may be requested, when indicated. Instrumental exams will be ordered by the cardiologist. For COVID-19 patients who develop cardiac complications (from arrhythmias to myocardial infarction), the hospitalization must be located in the COVID area based on the need for care (low, sub-intensive, intensive) and not on the basis of medical specialization regarding the possible complication. In other words, the area intended for COVID-19 patients, structured according to the level of needed care, should host COVID-19 patients regardless of associated comorbidity as it is unconceivable that every specialty ward be equipped with a mini isolation unit. Potentially deferrable activities are shown in Table 1 . Obviously, the choice to defer procedures/tests must always be made after rigorous evaluation of the clinical condition of the individual case and after careful evaluation of the risk/benefit ratio. [16] [17] [18] Interventional cardiology After rigorous evaluation of the clinical condition of the individual case and after careful evaluation of the risk/benefit ratio, the following procedures are potentially deferrable (among others): • coronary angiography/angioplasty for stable coronary artery disease; • preoperative coronary angiography for non-cardiac surgery; • interventions for chronic total coronary occlusions; and • transcatheter aortic valve implantation for asymptomatic patients The data that support the findings of this study are available from the corresponding author, SV, upon reasonable request. This Position Paper was originally published in the Italian language in "Giornale Italiano di Cardiologia", official journal of Italian Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV COVID-19 and the cardiovascular system Myocardial injury in patients with COVID-19 pneumonia How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19 Virtually perfect? Telemedicine for Covid-19 The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy SARS-CoV-2 cell entry depends on ACE2 and Considerations on In-Hospital Cardiological Consultations and Cardiology Out-Patient Clinics during COVID-19 pandemic G231 TMPRSS2 and is blocked by a clinically proven protease inhibitor Inhibitors of RAS might be a good choice for the therapy of COVID-19 Pneumonia Interactions with experimental COVID-19 therapies Position Paper ANMCO: Gestio-ne dei pazienti con sospetto o conclama-to COVID-19 e necessità di procedure di elettrofisiologia e/o elettrostimolazione urgenti Guidance from the CCS COVID-19 Rapid Response Team General guidance on deferring nonurgent cardiovascular testing and procedures during the COVID-19 pandemic